Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Technetium-99m (v) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: Experience in imaging

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5820415

A recently developed imaging agent, technetium-99m (v) dimercaptosuccinic acid (/sup 99m/Tc (v) DMSA), has been used to assess head and neck squamous carcinoma (SCC). We have prospectively studied 62 patients of whom 53 had a histologically proven head and neck SCC. The remaining nine had benign lesions. The results of planar imaging in patients with primary disease yielded an 85% sensitivity and 78% specificity. Planar imaging in patients with cervical lymphadenopathy revealed a 59% sensitivity. Nineteen patients also had single photon emission computed tomography imaging which improved the image quality, spatial resolution and sensitivity of the investigation. Twenty-seven patients were scanned before and after radiotherapy and, of these, 96% showed positive uptake in the salivary glands with no evidence of tumor recurrence. This study has shown /sup 99m/Tc (v) DMSA imaging provides a cheap and rapid method of investigating head and neck SCC and further studies are necessary to evaluate its role in the management of patients with this disease.

Research Organization:
Guy's Hospital, London (England)
OSTI ID:
5820415
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 30:2; ISSN JNMEA
Country of Publication:
United States
Language:
English